• Return to Headlines

Relatively Good Performance Detected in Shares of Akebia Therapeut in the Biotechnology Industry (AKBA , FOLD , NVTA , BPMC , CTMX )

By Amy Schwartz

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the potential to outperform.

Akebia Therapeut (NASDAQ:AKBA ) ranks first with a gain of 7.10%; Amicus Therapeut (NASDAQ:FOLD ) ranks second with a gain of 5.88%; and Invitae Corp (NYSE:NVTA ) ranks third with a gain of 4.94%.

Blueprint Medici (NASDAQ:BPMC ) follows with a gain of 4.70% and Cytomx Therapeut (NASDAQ:CTMX ) rounds out the top five with a gain of 3.65%.

SmarTrend recommended that subscribers consider buying shares of Akebia Therapeut on November 25th, 2019 as our technology indicated a new Uptrend was in progress when shares hit $4.54. Since that recommendation, shares of Akebia Therapeut have risen 52.0%. We continue to monitor Akebia Therapeut for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: relative performance akebia therapeut amicus therapeut invitae corp blueprint medici cytomx therapeut

Ticker(s): AKBA FOLD NVTA BPMC CTMX